Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Brain Injury, Chronic

ClinicalTrials.gov lists 45 trials for Brain Injury, Chronic or a narrower condition beneath it. MD Stem Cells has the most among industry and government lead sponsors, with 2.

MeSH D020208 Nervous System Diseases C10 C23 C26 Listed by Orphanet as a rare disease
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 1 Phase 1 2 Phase 1/2 Phase 1/2 2 Phase 2 Phase 2 5 Phase 3 Phase 3 1 Not applicable Not applicable 16 Observational Observational 19 Phase 1 Phase 1 2 Phase 1/2 Phase 1/2 2 Phase 2 Phase 2 5 Phase 3 Phase 3 1 Not applicable Not applicable 16 Observational Observational 19

Trials per phase

19 of the 45 trials are tagged with Brain Injury, Chronic itself; the rest are tagged with a narrower condition beneath it.

Get the Brain Injury, Chronic report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Brain Injury, Chronic trials start? (16)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year. 1 trial is registered to start in 2027 or later, and not listed here.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 3
  • Not applicable
  • Observational

Top of scale: 10

2003: 1 trials (Observational 1) 2009: 1 trials (Phase 1/2 1) 2011: 3 trials (Observational 2, Not applicable 1) 2013: 3 trials (Observational 3) 2014: 2 trials (Phase 2 1, Phase 1 1) 2015: 2 trials (Observational 1, Phase 2 1) 2016: 6 trials (Observational 1, Not applicable 4, Phase 1/2 1) 2017: 2 trials (Phase 2 2) 2018: 3 trials (Not applicable 2, Phase 2 1) 2019: 1 trials (Not applicable 1) 2021: 10 trials (Observational 6, Not applicable 4) 2022: 1 trials (Not applicable 1) 2023: 2 trials (Not applicable 1, Phase 1 1) 2024: 2 trials (Observational 2) 2025: 4 trials (Observational 1, Not applicable 2, Phase 3 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 1
2025 4
2024 2
2023 2
2022 1
2021 10
2019 1
2018 3
2017 2
2016 6

No forecast is made for this condition: it averages 2.6 trial starts a year over the five years to September, under the 5 a year the method needs.

Prediction, not a registry value: median of 36 months from start to primary completion across 5 trials still running at the 2026-10-09 snapshot; registered median of 25 months across 24 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Brain Injury, Chronic trials in? (6)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 1 2
Phase 1/2 2
Phase 2 5
Phase 3 1
Not applicable 16
Observational 19

How many Brain Injury, Chronic trials are recruiting? (7)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Not yet recruiting 2
Recruiting 9
Enrolling by invitation 1
Completed 21
Terminated 1

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Brain Injury, Chronic trials? (5)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
MD Stem Cells 2
Avid Radiopharmaceuticals 1
Centre for Neuro Skills 1
CereMark Pharma, LLC 1
East Kent Hospitals University NHS Foundation Trust 1

Interventions as named in the registry (15)

Shown in this order: most trials first.

Interventions as named in the registry
Drug Trials
Hyperbaric Oxygen 1
Amyvid PET Scan 1
cerebrospinal fluid 1
Intranasal auto-M2-BFs 1
MUSE Stem Cell Therapy 1

These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.

Which publications cover Brain Injury, Chronic? (71)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Prevalence (1)

Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.

Prevalence
Orphanet disease Type Class Geography Jurisdiction Mapping relation
Dementia pugilistica Point prevalence <1 / 1 000 000 Worldwide Not stated Unspecified

Sub-conditions in MeSH (1)

MeSH descendants one level down with at least one trial, most trials first.

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: serious adverse events in this condition's trials and rare-disease identity.

Browse all condition evidence pages